Search

everythinglearnresearchcommunity

for

Search:↓

The DLQI is a key tool for measuring quality of life in dermatology.

There is a significant need for better-validated quality of life tools in dermatology.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

The hair and oil glands react by changing structure when stressed.

A TP63 gene mutation causes significant hair loss and mild skin, nail, and tooth abnormalities.

A woman with a rare hormone resistance condition also had missing teeth and hair loss, which might be new symptoms of her genetic disorder.

Early diagnosis and genetic evaluation of ADULT syndrome are crucial to reduce stress and medical costs.

FR-1 reduces skin scarring and promotes healing without harmful effects.

Targeting the p63 gene could help treat skin diseases.

Microneedles could revolutionize pediatric medicine by offering painless drug delivery, but more development is needed.

More skin issues appeared in the emergency department during COVID-19, highlighting the need for better dermatology training and resources.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

The Virtual Magic Wand program successfully trained dermatologists in innovation, with most feeling capable of leading innovation teams and many starting companies.

YH0618 helped reduce skin and nail problems and fatigue in chemotherapy patients.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

Platelet-rich plasma speeds up skin wound healing.

Follicular mucinosis can be an early sign of aggressive mycosis fungoides.

Botulinum toxins effectively treat excessive sweating and may help with other skin conditions, but more research is needed.

β-catenin, Shh, and Bmp signaling control hair follicle development.

Blue light can help treat skin conditions like eczema and acne without major side effects.

Chemotherapy is crucial for treating gynecological cancers but requires careful management due to severe side effects.

Low BMI and cold exposure increase the risk of chilblains.

Piezoelectric Nanogenerators are promising for non-invasive health monitoring but need efficiency and durability improvements.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

A scalp infection by Mycobacterium abscessus can cause hair loss even in healthy individuals and may be misdiagnosed.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.